RANDOMIZED PHASE III TRIAL COMPARING GAMMA KNIFE (GK) AND LINAC BASED (EDGE) RADIOSURGERY FOR BRAIN METASTASES FROM SOLID TUMORS: RESULTS FROM THE GADGET TRIAL

被引：0
|
作者：
Clerici, E. [1 ]
Navarria, P. [1 ]
Franzese, C. [1 ]
Carta, G. A. [1 ]
Mancosu, P. [1 ]
Reggiori, G. [1 ]
Picozzi, P. [1 ]
Attuati, L. [1 ]
Tomatis, S. [1 ]
Scorsetti, M. [1 ,2 ]
机构：
[1] Humanitas Canc Ctr & Res Hosp, Rozzano, MI, Italy
[2] Humanitas Univ, Milan, Italy
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS6.5
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial
    Li, Huiping
    Huang, Yan
    Chen, Zhendong
    Zeng, Aiping
    Zhang, Helong
    Yu, Yan
    Wei, Shihong
    Li, Qingshan
    Wang, Xiaojia
    Wang, Xiangcai
    Wang, Xiuwen
    Yang, Runxiang
    Dai, Xiumei
    Bi, Minghong
    Sun, Tao
    Zhang, Qingyuan
    Han, Cuicui
    Li, Yujie
    Kang, Xiaoyan
    Liu, Yaxin
    Zhang, Li
    BIODRUGS, 2023, 37 (02) : 259 - 269
  • [32] Radiosurgery followed by tumour treating fields (TTFields) for brain metastases (1-10) from NSCLC in the phase III METIS trial
    Mehta, M.
    Gondi, V.
    Ahluwalia, M.
    Brown, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
    Soffietti, Riccardo
    Kocher, Martin
    Abacioglu, Ufuk M.
    Villa, Salvador
    Fauchon, Francois
    Baumert, Brigitta G.
    Fariselli, Laura
    Tzuk-Shina, Tzahala
    Kortmann, Rolf-Dieter
    Carrie, Christian
    Ben Hassel, Mohamed
    Kouri, Mauri
    Valeinis, Egils
    van den Berge, Dirk
    Mueller, Rolf-Peter
    Tridello, Gloria
    Collette, Laurence
    Bottomley, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : 65 - 72
  • [34] Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
    Javier Cortés
    Hope S. Rugo
    Ahmad Awada
    Chris Twelves
    Edith A. Perez
    Seock–Ah Im
    Patricia Gómez-Pardo
    Lee S. Schwartzberg
    Veronique Diéras
    Denise A. Yardley
    David A. Potter
    Audrey Mailliez
    Alvaro Moreno-Aspitia
    Jin-Seok Ahn
    Carol Zhao
    Ute Hoch
    Mary Tagliaferri
    Alison L. Hannah
    Joyce O’Shaughnessy
    Breast Cancer Research and Treatment, 2017, 166 : 327 - 328
  • [35] Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases, first results from a phase III randomized controlled multicenter trial (the SCANDIUM trial).
    Bagge, Roger Olofsson
    Nelson, Axel
    Shafazand, Amir
    All-Ericsson, Charlotta
    Cahlin, Christian
    Elander, Nils
    Helgadottir, Hildur
    Kiilgaard, Jens Folke
    Kinhult, Sara
    Ljuslinder, Ingrid
    Rizell, Magnus
    Eilard, Malin Sternby
    Ullenhag, Gustav J.
    Nilsson, Jonas A.
    Ny, Lars
    Lindner, Per
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17)
  • [36] A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Barker, Christopher A.
    DAngelo, Sandra P.
    Wasilewski, Gloria
    Steckler, Alexa M.
    Lian, Ming
    Zhang, Zhigang
    Chapman, Paul B.
    Shoushtari, Alexander N.
    Ariyan, Charlotte E.
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [37] Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial
    Ran, Ran
    Li, Hongtao
    Sun, Tao
    Zhou, Huan
    Zang, Aimin
    Guo, Hongqian
    Xie, Hua
    Wu, Shikai
    Yan, Yong
    Yin, Xing
    Xiong, Hailin
    Li, Hong
    Yuan, Jing
    Wang, Juan
    Li, Huiping
    Li, Jin
    INTERNATIONAL JOURNAL OF CANCER, 2025,
  • [38] Stereotactic Radiosurgery versus Whole-brain Radiation Therapy for Patients with 4-15 Brain Metastases: A Phase III Randomized Controlled Trial
    Li, J.
    Ludmir, E. B.
    Wang, Y.
    Guha-Thakurta, N.
    McAleer, M. F.
    Settle, S. H., Jr.
    Yeboa, D. N.
    Ghia, A. J.
    McGovern, S. L.
    Chung, C.
    Woodhouse, K. D.
    Briere, T. M.
    Sullaway, C. M.
    Liu, D. D.
    Rao, G.
    Chang, E. L.
    Mahajan, A.
    Sulman, E. P.
    Brown, P. D.
    Wefel, J. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S21 - S22
  • [39] Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial
    Kepka, L.
    Tyc-Szczepaniak, D.
    Osowiecka, K.
    Sprawka, A.
    Trabska-Kluch, B.
    Czeremszynska, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (02): : 150 - 159
  • [40] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
    Andrews, DW
    Scott, CB
    Sperduto, PW
    Flanders, AE
    Gaspar, LE
    Schell, MC
    Werner-Wasik, M
    Demas, W
    Ryu, J
    Bahary, JP
    Souhami, L
    Rotman, M
    Mehta, MP
    Curran, WJ
    LANCET, 2004, 363 (9422): : 1665 - 1672
12345